Delivery Order SPE2DB25D3404-SPE2DB25FUNYS

Award Date 6/23/25
Potential Completion Date 6/24/25
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the provision of PROVOCHOLINE 100 MG VIALS. The contract, valued at $2,825.57, has a period of performance through July 26, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, including military and veterans'...
This federal contract award, valued at $3,332.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,964,091 units of PROVOCHOLINE 100 MG VIALS, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 21, 2025. The contract is not set aside for any specific type of business. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,650.39, is for the supply of PROVOCHOLINE INHAL SOLN PACK 18ML, a medical product. The contract has a firm fixed price pricing type and a period of performance through March 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and...
The U.S. Defense Logistics Agency (DLA) awarded a $1,178.84 Firm Fixed Price Delivery Order to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4565752597 PROVOCHOLINE INHAL SOLN PACK 18ML and has an ultimate completion date of September 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This federal contract award is for the delivery of PROVOCHOLINE 100 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 24, 2024, with a ceiling value of $1,886.52 and a completion date of May 28, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of PROVOCHOLINE 100 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,530.47, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Provocholine 100 mg vials. The contract has a firm fixed price of $4,395.22 and an ultimate completion date of July 24, 2024. There is no set-aside designation on this contract. AmerisourceBergen Drug Corp has been awarded numerous federal contracts by the DLA and other agencies, including a $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,295.64 firm-fixed-price contract is for the supply of Provocholine Inhalation Solution, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the provision of 4,563,516,350 vials of the pharmaceutical product Provocholine 100 mg. The total potential value of this order is $2,515.36, with a period of performance running through February 2, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $12,184.75 firm fixed price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4565618364 - PROVOCHOLINE INHAL SOLN PACK 18ML, with an ultimate completion date of August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUNYS
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,295.11, is for the delivery of 4568618822 PROVOCHOLINE 100 MG VIALS. The contract is a firm fixed-price delivery order, with an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract award is not designated as a set-aside.

Generated 9/22/25, 9:47 AM